Single vs. multiple fraction non-inferiority trial of stereotactic ablative radiotherapy for the comprehensive treatment of oligo-metastases/progression: SIMPLIFY-SABR-COMET.

Olson R, Abraham H, Leclerc C, Benny A, Baker S, Matthews Q, Chng N, Bergman A, Mou B, Dunne EM, Schellenberg D, Jiang W, Chan E, Atrchian S, Lefresne S, Carolan H, Valev B, Tyldesley S, Bang A, Berrang T, Clark H, Hsu F, Louie AV, Warner A, Palma DA, Howell D, Barry A, Dawson L, Grendarova P, Walker D, Sinha R, Tsai J, Bahig H, Thibault I, Koul R, Senthi S, Phillips I, Grose D, Kelly P, Armstrong J, McDermott R, Johnstone C, Vasan S, Aherne N, Harrow S, Liu M

Open source

DOI
10.1186/s12885-024-11905-7
Published
2024 Feb 3
Container
BMC cancer
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12885-024-11905-7,
  title = {Single vs. multiple fraction non-inferiority trial of stereotactic ablative radiotherapy for the comprehensive treatment of oligo-metastases/progression: SIMPLIFY-SABR-COMET.},
  author = {Olson R and Abraham H and Leclerc C and Benny A and Baker S and Matthews Q and Chng N and Bergman A and Mou B and Dunne EM and Schellenberg D and Jiang W and Chan E and Atrchian S and Lefresne S and Carolan H and Valev B and Tyldesley S and Bang A and Berrang T and Clark H and Hsu F and Louie AV and Warner A and Palma DA and Howell D and Barry A and Dawson L and Grendarova P and Walker D and Sinha R and Tsai J and Bahig H and Thibault I and Koul R and Senthi S and Phillips I and Grose D and Kelly P and Armstrong J and McDermott R and Johnstone C and Vasan S and Aherne N and Harrow S and Liu M},
  year = {2024},
  journal = {BMC cancer},
  doi = {10.1186/s12885-024-11905-7},
  url = {https://doi.org/10.1186/s12885-024-11905-7}
}

RIS

TY  - JOUR
TI  - Single vs. multiple fraction non-inferiority trial of stereotactic ablative radiotherapy for the comprehensive treatment of oligo-metastases/progression: SIMPLIFY-SABR-COMET.
AU  - Olson R
AU  - Abraham H
AU  - Leclerc C
AU  - Benny A
AU  - Baker S
AU  - Matthews Q
AU  - Chng N
AU  - Bergman A
AU  - Mou B
AU  - Dunne EM
AU  - Schellenberg D
AU  - Jiang W
AU  - Chan E
AU  - Atrchian S
AU  - Lefresne S
AU  - Carolan H
AU  - Valev B
AU  - Tyldesley S
AU  - Bang A
AU  - Berrang T
AU  - Clark H
AU  - Hsu F
AU  - Louie AV
AU  - Warner A
AU  - Palma DA
AU  - Howell D
AU  - Barry A
AU  - Dawson L
AU  - Grendarova P
AU  - Walker D
AU  - Sinha R
AU  - Tsai J
AU  - Bahig H
AU  - Thibault I
AU  - Koul R
AU  - Senthi S
AU  - Phillips I
AU  - Grose D
AU  - Kelly P
AU  - Armstrong J
AU  - McDermott R
AU  - Johnstone C
AU  - Vasan S
AU  - Aherne N
AU  - Harrow S
AU  - Liu M
PY  - 2024
JO  - BMC cancer
DO  - 10.1186/s12885-024-11905-7
UR  - https://doi.org/10.1186/s12885-024-11905-7
ER  - 

APA

R, O., H, A., C, L., A, B., S, B., Q, M., N, C., A, B., B, M., EM, D., D, S., W, J., E, C., S, A., S, L., H, C., B, V., S, T., A, B., T, B., H, C., F, H., AV, L., A, W., DA, P., D, H., A, B., L, D., P, G., D, W., R, S., J, T., H, B., I, T., R, K., S, S., I, P., D, G., P, K., J, A., R, M., C, J., S, V., N, A., S, H., & M, L. (2024). Single vs. multiple fraction non-inferiority trial of stereotactic ablative radiotherapy for the comprehensive treatment of oligo-metastases/progression: SIMPLIFY-SABR-COMET.. BMC cancer. https://doi.org/10.1186/s12885-024-11905-7

Source records